JW THERAP-B News

JW THERAP-B: VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE RECEIPT OF BREAKTHROUGH THERAPY DESIGNATION FOR CARTEYVA IN CHINA AS SECOND-LINE TREATMENT IN RELAPSED OR REFRACTORY ADULT LARGE B-CELL LYMPHOMA

Jan 10 03:30 ET

JW THERAP-B: GRANT OF SHARE OPTIONS AND GRANT OF RESTRICTED SHARE UNITS

Jan 6 06:18 ET

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024

Jan 6 04:36 ET

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024

Dec 5, 2024 03:29 ET

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024

Nov 5, 2024 04:15 ET

JW THERAP-B: CHANGE OF AUDITOR

Oct 31, 2024 04:30 ET

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024

Oct 7, 2024 04:33 ET

JW THERAP-B: 2024 INTERIM REPORT

Sep 26, 2024 04:34 ET

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

Sep 5, 2024 00:06 ET

JW THERAP-B: GRANT OF SHARE OPTIONS AND GRANT OF RESTRICTED SHARE UNITS

Sep 2, 2024 07:29 ET

JW THERAP-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

Aug 28, 2024 07:52 ET

JW THERAP-B: CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND CHANGE OF COMPOSITION OF BOARD COMMITTEES

Aug 28, 2024 07:45 ET

JW THERAP-B: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024

Aug 28, 2024 04:35 ET

JW THERAP-B: VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE NMPA ACCEPTANCE OF SUPPLEMENTAL BIOLOGICAL LICENSE APPLICATION OF CARTEYVA IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY MENTLE CELL LYMPHOMA

Aug 27, 2024 04:37 ET

JW THERAP-B: NOTICE OF BOARD MEETING

Aug 14, 2024 04:36 ET

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 5, 2024 05:36 ET

JW THERAP-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

Jul 31, 2024 05:57 ET

JW THERAP-B: CHANGE OF CHIEF EXECUTIVE OFFICER, APPOINTMENT, REDESIGNATION AND RESIGNATION OF DIRECTORS, CHANGE OF COMPOSITION OF BOARD COMMITTEES AND CHANGE OF AUTHORIZED REPRESENTATIVE

Jul 31, 2024 05:54 ET

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 3, 2024 04:37 ET

JW THERAP-B: NINTH AMENDED AND RESTATEDMEMORANDUM AND ARTICLES OF ASSOCIATION

Jun 18, 2024 05:02 ET